http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110430905-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6cb7a0a91bb1b458787f21794a256b9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3317 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01D5-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31568 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01B7-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G05B13-041 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-20 |
| filingDate | 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16cc6599b67fe7746bf78e9dbe22fc39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cee49298dfe8b655b3cf18796dedfb00 |
| publicationDate | 2019-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110430905-A |
| titleOfInvention | Dose control system for injectable drug delivery device and method of use |
| abstract | The present invention relates to a dose control system for an injectable drug delivery device. The device includes a substantially disc-shaped diameter single-stage magnet removably attached or permanently fixed to a rotatable dose wheel at the proximal end of the drug delivery device body; a housing removably attached to the proximal end of the drug delivery body and includes at least first and second magnetic field measurement devices configured to measure the magnetic field produced by the magnet. The integrated control unit is connected to the magnetic field measurement device and is configured to process information received therefrom. The magnetic field measuring device is located in the housing in axial displacement relationship with respect to the longitudinal axis of the drug delivery body and the magnet, the magnet is configured to rotate with the dose setting wheel about the longitudinal axis of the drug delivery body, and the integrated control unit may also provide information on The normalized vector of the axial displacement relationship of the magnetic field measurement device, which is derived from the measurement magnetic field generated by the rotation of the magnet and measured by the magnetic field measurement device. Dose settings are calculated from normalized vectors. |
| priorityDate | 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.